IPO - VOLITIONRX LTD

Form Type: S-1

Filing Date: 2025-04-04

Corporate Action: Ipo

Type: New

Accession Number: 000147793225002474

Filing Summary: VolitionRx Limited filed a registration statement on Form S-1 with the SEC on April 4, 2025, for the proposed offering of up to 35,867,306 shares of its common stock, par value $0.001 per share. This includes various categories of warrant shares: 448,500 Underwriter Warrant Shares, 3,557,273 Pre-Funded Warrant Shares, and others including Series A and B Warrant Shares. The company intends to withdraw these shares from a previously filed Shelf Registration Statement, indicating a strategic shift to formalize a direct public offering. As of April 3, 2025, the company had 100,746,467 shares outstanding, and issuing the new shares would represent approximately 26.3% of the total shares outstanding. Potential risks include stock price volatility, dilution of current shareholders' interests, and compliance with NYSE American listing requirements. VolitionRx is positioned to leverage patented technologies in the diagnostics market, aiming to provide early diagnosis and monitoring of diseases through innovative blood tests.

Document Link: View Document